GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling

Oncotarget

Volumn 6, Issue 6, 2015, Pages 4345-4356

  Li, Yang ^a   Ke, Qiang ^a   Shao, Yangguang ^a   Zhu, Ge ^a   Li, Yanshu ^a   Geng, Nanxi ^a   Jin, Feng ^a   Li, Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EMT; GATA1; PAK5; Phosphorylation

Indexed keywords

HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 5; SERINE; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; GATA1 PROTEIN, HUMAN; PAK7 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; BREAST METASTASIS; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE; PATHOGENESIS; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; P21-ACTIVATED KINASES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84924274244     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2999     Document Type: Article

References (35)

1. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9:265-273.
2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139:871-890.
3. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7:131-142.
4. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009; 28:15-33.
5. Cowin P, Welch DR. Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. J Mammary Gland Biol Neoplasia. 2007; 12:99-102.
6. Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y, Orkin SH. Targeted deletion of a high-affinity GATA-binding site in the GATA1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002; 195:1387-1395.
7. Szalai G, LaRue AC, Watson DK. Molecular mechanisms of megakaryopoiesis. Cell Mol Life Sci. 2006; 63:2460-2476.
8. Lowry JA, Mackay JP. GATA1: one protein, many partners. Int J Biochem Cell Biol. 2006; 38:6-11.
9. Boidot R, Végran F, Jacob D, Chevrier S, Cadouot M, Feron O, Solary E, Lizard-Nacol S. The transcription factor GATA1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene. 2010; 29:2577-2584.
10. Seo M, Liu X, Chang M, Park J. GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells. Int J Oncol. 2012; 40:655-664.
11. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer. 2006; 6:459-471.
12. Li X, Liu F, Li F. PAKs as a therapeutic target in gastric cancer. Expert Opin Ther Targets. 2010; 14:419-433.
13. Whale A, Hashim FN, Fram S, Jones GE, Wells CM. Signalling to cancer cell invasion through PAK family kinases. Front Biosci. 2011; 16:849-864.
14. Radu M, Semenova G, Kosoff R, Chernoff J. PAK signalling during the development and progression of cancer. Nat Rev Cancer. 2014; 14:13-25.
15. Dan C, Nath N, Liberto M, Minden A. PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol. 2002; 22:567-577.
16. Faure S, Cau J, de Santa Barbara P, Bigou S, Ge Q, Delsert C, Morin N. Xenopus p21-activated kinase 5 regulates blastomeres' adhesive properties during convergent extension movements. Dev Biol. 2005; 277:472-492.
17. Gong W, An Z, Wang Y, Pan X, Fang W, Jiang B, Zhang H. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. Int J Cancer. 2009; 125:548-555.
18. Cotteret S, Chernoff J. Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties. Mol Cell Biol. 2006; 26:3215-3230.
19. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010; 285:14042-14051.
20. Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009; 384:6-11.
21. Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei X, Gao J, Zhao Z, Liu C. Oct-4 and nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget. 2014; 5:10803-10815.
22. Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, Green AL, Vyas P, Porcher C. Genome-wide indentification of TAL1's functional targets: Insights into its mechanisms of action in primary erythroid cells. Genome Res. 2010; 20:1064-1083.
23. Shao Y, Li Y, Zhang J, Liu D, Liu F, Zhao Y, Shen T, Li F. Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX. Nucleic Acids Res. 2010; 38:2813-2824.
24. Wang XX, Cheng Q, Zhang SN, Qian HY, Wu JX, Tian H, Pei DS, Zheng JN. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell. Tumor Biology. 2013; 34:2721-2729.
25. Lozano E, Frasa MA, Smolarczyk K, Knaus UG, Braga VM. PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac. J Cell Sci. 2008; 121:933-938.
26. Li L, Liu C, Amato RJ, Chang JT, Du G, Li W. CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression. Oncotarget. 2014; 5:10840-10853.
27. Hardy KM, Booth BW, Hendrix MJ, Salomon DS, Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2010; 15:191-199.
28. Côme C, Arnoux V, Bibeau F, Savagner P. Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia. 2004; 9:183-193.
29. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005; 33:6566-6578.
30. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem. 2001; 276:27424-27431.
31. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, play an essential role in tumor metastasis. Cell. 2004; 117:927-939.
32. Daniel AR, Lange CA. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc Natl Acad Sci USA. 2009; 106:14287-14292.
33. Kadri Z, Maouche-Chretien L, Rooke HM, Orkin SH, Romeo PH, Mayeux P, Chretien S. Phosphatidylinositol 3-Kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA1-1 competent for TIMP-1 gene transactivation. Molecular and Cellular Biology. 2005; 25:7412-7422.
34. Zheng H, Yang L, Peng L, Lzumi V, Koomen J, Seto E, Chen J. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1. Mol Cell Biol. 2013; 33:4960-4970.
35. Guo Hong, Friedman Alan D. Phosphorylation of RUNX1 by Cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3. J Biol Chem. 2011; 286:208-215.